ArticleCancer medicine2025

A Phase 1 Trial of Fimepinostat in Children and Adolescents With Relapsed and Refractory Solid and CNS Tumors.

David S Shulman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.